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Cytochrome P450 2C8 is responsible for 10% of drug metabolism in human liver. Among its 
substrates are the anticancer drug paclitaxel and the antimalarial amodiaquine. In order to 
meet the need of a reliable and fast drug screening assay for P450, this project aims at the 
construction of a P450 2C8 electrode. 
The CYP2C8 gene was cloned and expressed in E.coli leading to 490 nmoles/l of pure 
protein as determined spectrophotometrically with CO binding. An apparent Km of 26.2 ± 4.7 
µM was measured for the paclitaxel product (HPLC). The recombinant enzyme was then 
immobilized on glassy carbon (GC) electrodes modified either with the polyelectrolyte PDDA 
or gold nanoparticles. Cyclic voltammograms of P450 2C8 showed a reversible redox couple 
centered around –305 mV with both immobilization approaches. Electrochemically driven 
catalysis of the immobilized protein was also performed by chronoamperometry using 
paclitaxel as substrate. An apparent Km of 50 µM was measured, in good agreement with data 
obtained in solution. 
This is the first successful immobilization of an active P450 2C8 on GC electrodes, an 
important step towards the development of a P450-based drug discovery array.  
